Consider This from NPR Folgen

It was the year of Beyoncé! It was the year of Taylor! Both musicians had highly successful tours, highly successful concert films and both women pumped billions into the economy. And each has been supportive of the other this year, and in the past. So why is there a narrative that they're rivals? NPR's Juana Summers revisits the year that was for Beyoncé and Swift, and talks to Miami University of Ohio Music Professor Tammy L. Kernodle about the tendency of society, and the media, to pit successful women in the music industry against one another. Email us at considerthis@npr.orgLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Nearly two years into Roe v. Wade being overturned, pregnant people continue to have a hard time accessing abortion and miscarriage care. This year saw the addition of new restrictive abortion laws in some states and protection of existing abortion laws in others. What does this mean for abortion care in 2024, and how might all of this affect the 2024 elections?NPR's Juana Summers digs into these questions with health policy reporter Selena Simmons-Duffin and national political correspondent Sarah McCammon.Email us at considerthis@npr.orgLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Americans are increasingly using drugs like Ozempic, Wegovy and Mounjaro to lose weight. And they got a big endorsement last week when Oprah Winfrey announced that she, too was using weight loss drugs.And it's not just Oprah, the decades-old weight management company Weight Watchers is also embracing the drugs, integrating them into the business model.NPR's Juana Summers speaks with Weight Watchers CEO Sima Sistani about the company's decision, and talks to NPR consumer health correspondent Yuki Noguchi about what is known and unknown about these drugs.Email us at considerthis@npr.orgLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy